Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1994 Nov-Dec;40(6):716-21.

Antibiotics, biliary sepsis, and bile duct stones

Affiliations
  • PMID: 7859970

Antibiotics, biliary sepsis, and bile duct stones

J W Leung et al. Gastrointest Endosc. 1994 Nov-Dec.

Abstract

Bacteriologic studies of bile and blood cultures of 579 patients with ductal stones and infected bile revealed that 121 patients (21%) had associated bacteremia. Analysis of bile and stone cultures showed that Escherichia coli, Klebsiella sp, Enterobacter sp, Enterococcus sp, and Streptococcus sp were the most commonly isolated bacteria. Two-thirds of the patients with bacteremia had similar organisms isolated from blood and bile. Pharmacokinetic studies of the hepatic/biliary excretion profiles of ceftazidime, cefoperazone, imipenem, netilmicin, and ciprofloxacin were performed by ERCP and nasobiliary catheter drainage. The bile samples obtained immediately after cannulation from patients with complete biliary obstruction contained low or undetectable levels of the antibiotics administered--the exception being ciprofloxacin, which was present at a concentration of 20% of the serum level. In vitro determination of minimum inhibitory concentration of the aforementioned antibiotics against 199 isolates of biliary pathogens revealed imipenem and ciprofloxacin to have the highest antimicrobial activity. Based on pharmacokinetic studies and in vitro susceptibility findings, we conclude that ciprofloxacin is superior to the other tested antibiotics in prophylaxis and treatment of biliary sepsis.

PubMed Disclaimer

Comment in

  • Antibiotic therapy of cholangitis.
    Henry MJ. Henry MJ. Gastrointest Endosc. 1995 Sep;42(3):276-7. doi: 10.1016/s0016-5107(95)70111-7. Gastrointest Endosc. 1995. PMID: 7498701 No abstract available.
  • Antibiotic prophylaxis of ERCP with ciprofloxacin.
    Mohandas KM, Kelker R. Mohandas KM, et al. Gastrointest Endosc. 1996 Feb;43(2 Pt 1):175. doi: 10.1016/s0016-5107(06)80130-6. Gastrointest Endosc. 1996. PMID: 8635722 No abstract available.
  • [No title available]
    Leung JW. Leung JW. Gastrointest Endosc. 1995 Sep;42(3):276-277. doi: 10.1016/S0016-5107(95)70112-5. Epub 2005 Oct 28. Gastrointest Endosc. 1995. PMID: 28140018 No abstract available.

LinkOut - more resources